SCYNEXIS, Inc. (SCYX): Product News News

SCYX – Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in Vulvovaginal Candidiasis.

Key Facts Surrounding This News Item

  • SCYX had a POWR Rating of C (Neutral) coming into today.
  • SCYX was 3.18% above its 10-Day Moving Average coming into today.
  • SCYX was 0.39% above its 20-Day Moving Average coming into today.
  • SCYX was 9.81% above its 50-Day Moving Average coming into today.
  • SCYX was 14.92% above its 100-Day Moving Average coming into today.
  • SCYX was -1.81% below its 200-Day Moving Average coming into today.
  • SCYX had returned -24.57% year-to-date leading up to today’s news, versus a +5.02% return from the benchmark S&P 500 during the same period.

More Info About SCYNEXIS, Inc. (SCYX)

SCYNEXIS, Inc., a pharmaceutical company, develops and commercializes novel anti-infectives to address unmet therapeutic needs. Its lead product candidate includes SCY-078, which is in Phase I clinical trials of the intravenous formulation; Phase II clinical trials for the treatment of invasive candida infections; and Phase II clinical trials for unmet medical needs, such as vulvovaginal candidiasis. The company was founded in 1999 and is based in Jersey City, New Jersey. View our full SCYX ticker page with ratings, news, and more.

Try Premium Today!

Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

SCYX at a Glance

SCYX Current POWR Rating™
Overall POWR Rating™
SCYX Current Price $1.24 3.13%
More SCYX Ratings, Data, and News

SCYX Price Reaction

The day of this event (Jul. 10, 2018)
SCYX Closing Price$1.65 5.71%
SCYX Volume1,181,800
228.83% from avg
Leading up to this event
SCYX 1-mo returnN/A%
After this event
SCYX 1-day return8.85%
SCYX 3-day return9.33%
SCYX 5-day return4.89%

SCYX Price Chart

More SCYNEXIS, Inc. (SCYX) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All SCYX News
Page generated in 0.9196 seconds.